SBFM | Sunshine Biopharma, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.8000 - 2.8871
52 Week Range	2.4200 - 780.00
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	36,833
Average Volume	102,328
Shares Outstanding	1,224,340
Market Cap	3,452,639
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2022-02-15

Valuation
Profitability
Growth
Health
P/E Ratio	-0.01
Forward P/E Ratio	N/A
EPS	-378.25
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	44
Country	Canada
Website	SBFM

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).

SBFM's peers: AYTU, YCBD, COSM, FLGC, PTPI, SGIOY, ALIM, SXTC, GHSI, SHPH, LFCR, MNK, DERM, SNOA, TKNO, PAHC, SHMN, SSIC, EGRX, SBFMW

*Chart delayed

Analyzing fundamentals for SBFM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see SBFM Fundamentals page.

Watching at SBFM technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on SBFM Technicals page.